QT
ANAB icon

Quantamental Technologies’s AnaptysBio ANAB Stock Holding History

Quantamental Technologies’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-300
Closed -$10K – 468
2019
Q3 		$10K Buy
300
+102
+52% +$4.85K ﹤0.01% 1314
2019
Q2 		$11K Buy
+198
New +$14.3K ﹤0.01% 1231
2019
Q1 		– Sell
-600
Closed -$38K – 1456
2018
Q4 		$38K Buy
+600
New +$44.6K 0.02% 848

Other funds holding ANAB

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Quantamental Technologies's ANAB Position: Q4 2019 in Review

Quantamental Technologies sold out of AnaptysBio (ANAB) in Q4 2019, closing a stake of 300 shares — an estimated $10K sold.

Quantamental Technologies first reported a position in ANAB in Q4 2018 and held it in 3 quarters. The position peaked at $38K in Q4 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

  • Quantamental Technologies reported no remaining AnaptysBio position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 300 AnaptysBio shares in Q4 2019, an estimated $10K.
  • Quantamental Technologies first reported a position in AnaptysBio in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's AnaptysBio position peaked at $38K in Q4 2018.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.